ArticleAmerican journal of cancer research2022

Overexpression of transmembrane protein 102 implicates poor prognosis and chemoresistance in epithelial ovarian carcinoma patients.

Yi-Jou Tai et al.PubMed ↗Full text ↗

No numbers read from the abstract.